Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)
-
Upload
julius-harvey -
Category
Documents
-
view
219 -
download
0
Transcript of Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)
![Page 1: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/1.jpg)
Pitfalls in Pharmacotherapy of Geriatrics
DR Ali M. Alyami(M Pharm. , PhD)
![Page 2: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/2.jpg)
Case Study
An 85 year – old female with a history of atrial fibrillation, stroke, dementia, and hypertension, who is receiving chronic therapy with warfarin. Her primary care provider has been closing her warfarin to maintain her at an INR of 2.
![Page 3: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/3.jpg)
Case study
One evening, a covering physician is called with a report that the patient has developed a fever. The patient is initiated on empiric antibiotic therapy with cephalexin (500 PO TID for 7 days) to treat a presumed Urinary tract infection.
![Page 4: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/4.jpg)
Case study
The next morning the primary care physician is called with the previous day’s INR, 1.75. He increased the daily warfarin dose from 4 mg to 5 mg per day. He is not notified of cephalexin ordered the previous evening by the covering physician.
![Page 5: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/5.jpg)
Case study
One week later, the INR comes back at 13.8 and a covering physician is notified. That evening’s warfarin dose is held. The INR the following day is 16.1 . The warfarin continues to be held.
No vitamin K is administered.
![Page 6: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/6.jpg)
Case study
The very next day the patient develops congestion and shortness of breath. A chest X-ray reveals an infiltrate and the covering physician orders Augmentin 875 mg PO q12 hours for 10 days. The next day the patient passes tarry stool and omeprazole is initiated.
![Page 7: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/7.jpg)
Case study
The following morning the patient’s hematocrit is 25 and her INR is 11.3 . The primary care physician is notified, and vitamin K 10 mg SC is administered for 3 days with a decrease in INR to 0.9 . The physician writes that warfarin will not be reinitiated because anticoagulation has been difficult to control for unclear reasons.
![Page 8: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/8.jpg)
Major contributing factors to ADRs:Poor communication → increase < ADRsMultiple care ↑ prescribing cascade
(lack interface reconciliation)
![Page 9: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/9.jpg)
Prescribing Cascade
A new drug is prescribed to treat an adverse reaction to another drug in the mistaken belief that a new medical condition requiring treatment has developed.
![Page 10: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/10.jpg)
A Prescribing cascade
An 50 year – old female with a history of parkinson’s Disease treated with long – term sinemet therapy (25-100 TID). She has suffered occasional hallucinations attributed to the sinemet therapy, which have recently increased in frequency. The hallucinations sometimes involve large animals & can be quite terrifying.
![Page 11: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/11.jpg)
A Prescribing cascade
The patient is initialed on olanzapine 2.5 mg at bed time. Due to agitation & continued hallucinations, the olanzapine dose is increased to 5 mg and lorazepam 0.5 mg PO q4 hours prn is added to the medication regimen. The hallucinations continue & the evening dose of olanzepine is increased to 7.5 mg
![Page 12: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/12.jpg)
A Prescribing cascade
The patient is noted by the nursing staff to be shaky and stiff, but no change is made in the olanzepine dose. She becomes increasingly lethargic. She is described as rigid and stooped over with ambulation and begins to have more difficulty with activities of daily living including bathing, dressing, toileting, and transferring. She begins to require a wheelchair.
![Page 13: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/13.jpg)
A Prescribing cascade
The patient’s functional decline is attributed to Parkinson’s Disease ……..
![Page 14: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/14.jpg)
It is much easier to write upon a disease than upon a remedy. The former is in the hands of nature and a faithful observer with an eye of tolerable judgement cannot fail to delineate a likeness. The latter will ever be subject to the whim, the inaccuracies and blunder of mankind.
William Withering 1741-1799
![Page 15: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/15.jpg)
In the elderly, less medication is always better.
![Page 16: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/16.jpg)
Drug used in the elderly
• 40% of all elderly use > 5 drugs/week• 12% of elderly use > 10 drugs/week• 3-25% of prescriptions to elderly classified as
inappropriate.Sloane etal (2002 J. Am. Geriatr. Soc. 50,1001-1011)
Spore etal,. (1997 J. public. Health87, 404-409)
![Page 17: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/17.jpg)
ADRs in daily practice .……
SIZE OF THE PROBLEM10% of patients visiting general practices
showed one adverse drug event in the previous 6 months (AUST. Prscr 2011;34; 162-166)
ADRs 1.5 million/year (Med.J Aust. 2006; 184-646)
190000 hospital admission/year (Asut. Prescr 2011,34;162-166)
![Page 18: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/18.jpg)
Influence of poor communication
15% of patients will stop Rx vs. ADRs without advising their prescriber.
25% of patients report they did not receive info. about their Rx
![Page 19: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/19.jpg)
Factors influencing Drug Effects & risk of ADE in Geriatrics.
• Multiple Co-existing illnesses.• Polypharmacy :redundant effects & drug –
drug interactions.• Adverse drug effects nonspecific.• Pharmacologic changes with aging.• Limited knowledge base.• Medical errors – issue of patient safety.
![Page 20: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/20.jpg)
ALTERATIONS IN RESPONSE TO RxWITH AGEING
Pharmacokinetic Pharmacodynamic
![Page 21: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/21.jpg)
Common problems of drug administration in the elderly
• Reduced homeostasis.– Renal & hepatic functions.– Target organ sensitivity.
• Polypharmacy.– ADEs.
• Lack of available data fewer clinical trails.• Non- compliance.
![Page 22: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/22.jpg)
Pharmacokinetics changes with aging
• Absorption• Distribution.• Metabolism.• Excretion.
![Page 23: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/23.jpg)
Pharmacodynamics changes with ageing
![Page 24: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/24.jpg)
Physiological changes in elderly patients affecting pharmacodynamics
Target organ physiological changes– Increased sensitivity to pharmcological agents.– Decreased desirable effects of pharmacotherapy.– Increased ADEs
Homeostasis changes– Decreased capacity to respond to physiological
challenges & the adverse side effects of drug therapy
![Page 25: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/25.jpg)
TWO MAIN SOURCES OF ADRs RISKSTO THE ELDERLY
MISDIAGNOSIS & IMPROPER PRESCRIBING
NATURE OF PHARMACOLOGICAL ACTIONS OFPRESCRIBED MEDICATIONS
![Page 26: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/26.jpg)
Adverse Drug Reactions
• sensitivity to anticoagulants.• vit. K dependent clotting factors deficiency.• Pharmacokinetic changes.– Narrow therapeutic window– plasma protein.
• Drug interactions (e.g. phenytoin)• Adverse effect s(excessive internal bleeding.)
![Page 27: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/27.jpg)
Misdiagnosis & improper prescribing
![Page 28: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/28.jpg)
The Prescribing cascade(metoclopramide )Drug 1
Extrapyramidal effects ADE
L-Dopa Rx Drug 2
Proxy for ADE
![Page 29: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/29.jpg)
ACE inhibitor
ADRs e.g. postural hypertension
Rochon, P.A, Gurwitz JH. BMJ 1997;315 (1096-1099)
Prochlorperazine
Worse postural hypotension
Fall Hip fracture
Misdiagnosis Dizziness
![Page 30: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/30.jpg)
Medications involved in the prescribing Cascade
1st medication ADR 2nd medications
Cholinesterase inhibitors Urinary incontinence
Anticholinergic (oxybutynin)
Vasodilatorsß – blockers
Ca+2 channel blockersNSAIDs
Opiods analgesicsStatins, Seductives
ACE inhibitors
Dizziness Prochlorperazine
![Page 31: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/31.jpg)
Medications involved in the prescribing Cascade
1st medication ADR 2nd medications
NSAIDs ↑BP Antihypertension
Thiazide diuretics ↑uric acid (gout)
Allopurinol colchicine
Metochlopramide Movement disorder Levodopa
ACE inhibitors Cough
Paroxetine, Haloperidal Tremor Levodopa - Carbidopa
![Page 32: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/32.jpg)
Medications involved in the prescribing Cascade
1st medication ADR 2nd medications
Erythromycin Arrhythmia Anti – arrythmics
Antiepileptic Rash Topical corticosteroids
Antiepileptic Nausea MeoclopramideDomperidone
Antipsychotic Extrapyramidal adverse effect
Levodopa Anticholinergics
![Page 33: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/33.jpg)
Medications involved in the prescribing Cascade
1st medication ADR 2nd medications
Digoxin, NitratesLoop diureticsAntiepileptics,
AntibioticsACE inhibitors
Oral corticosteroidsNSAIDs
Opioid analgesicsTheophylline
Nausea Metoclopramide
![Page 34: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/34.jpg)
Pharmacological actions of prescribed medications
![Page 35: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/35.jpg)
ADR’s…
NSAIDs
• Frequently prescribed in geriatrics.• Pronounced GIT side effects.• Effect on kidney & CNS.
![Page 36: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/36.jpg)
ADRsCardiovascular Agents
• CHF is a common age-related condition.• Digoxin?
effective dose is variable.versus cardiac symptoms
Alternatives – Beta adrenergic receptor blockers– ACE inhibitors
![Page 37: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/37.jpg)
THERAPEUTICS GUIDELINES
BEER’S LISTSTOPP/START CRITERIA
![Page 38: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/38.jpg)
Beers Drugs Criteria• Originally compiled by Dr Mark Beers
in 1991.• First updated in 2003.
- Rxs to be avoided (Dose & Duration)
- Rxs to be avoided with certain diseases
![Page 39: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/39.jpg)
The Beer’s List (1991)
Arch. Intl. Med 163,22 2716-2724 (1991)2012 – updated by the AGS. J.Am. Geriatr. Soc., 10, 1532 – 1541
List of harmful Rx to the elderly.List of inappropriate Rx (disease, risk factors)List with Rx need to be used with caution.
Site www.Americangeriatrics.org
![Page 40: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/40.jpg)
Medications to avoid with concomitant diseases
• GIT Disorders - constipation - Ulcers
• Endocrine - Diabetes
• Cardiac• Urologic• Respiratory
![Page 41: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/41.jpg)
commonly used medications best avoided in geriatrics- Beer’s List
• Anticholinergic preparations.– Diphenlydramine– Amitriptyline– doxepin
• Benzodiazepines with active metabolites.– Diazepam (valium)– Chloradiazepoxide (librium)– Flurazepam (dalmene)
• Central acting CNS agents.– Alpha methyldopa (Aldomet)– Clonidine (catapres)
• Analgesics– Propoxyphene (darvon)– Pethidine– indomethacin
![Page 42: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/42.jpg)
STOPP/ START criteria
STOPP (( Screening Tool of older person’s potentially inappropriate prescriptions))START (( Screening Tool to Alert doctors to the Right Treatment))
Mode of actionP/KADRs
![Page 43: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/43.jpg)
STOPP criteria identifies (PIMs)
CVSLoop diuretics as first line monotherapy for hypertension.
Calcium channel blocker with chronic constipation.
Aspirin at dose > 150 mg/dayAspirin with no history of coronary, cerebral or peripheral vascular systems or occlusive event.
![Page 44: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/44.jpg)
STOPP criteria identifies PIM’S
Endocrine system:Glibenclamide or Chlorpropamide with type 2 DMDrugs that causes falls in predisposed elderly patients:Benzodiazepines.Neuroleptics.
![Page 45: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/45.jpg)
STOPP criteria identifies (PIMs)
CNSLong term ( > 1 month) neuroleptics as long term hypnotics or those with parkinsonism.Respiratory system:Nebulised ipratropium with glaucoma.
Long term (i.e. > 1 month), long – acting BZD’s, long acting metabolite (diazepam).
![Page 46: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/46.jpg)
STOPP criteria identifies (PIMs)
Duplicate drugs:Concurrent NSAIDsBenzodiazepines.
![Page 47: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/47.jpg)
STOPP/ START vs. BEER’S
STOPP & BEER’S criteria detected similar % of PIM 50 – 60 % of Patients.
STOPP →criteria more sensitive to detect PIMs than Beers & more ADRs than Beers criteria
![Page 48: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/48.jpg)
STOPP/ START criteria•Cardiovascular system:
STATINS →with a documented history of coronary or cerebral or peripheral vascular disease.Respiratory system:
Regular inhaled beta 2 agonist or anticholinergic agent for mild to moderate asthma or COPDCNS:
L-DOPA in idiopathic Parkinson's disease with definite functional impairment.
Antidepressant → depressive illness moderate to severe lasting at least 3 monthsCVS → omission of warfarin or aspirin in the presence of atrial fibrillation (AF).
![Page 49: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/49.jpg)
Points to consider before prescribing to an elderly
• Is drug therapy required?• Appropriate choice of drug & preparation.• Dosage regimen vs physiology.• Close monitoring & re-evalution.• Clear & simple instructions
![Page 50: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/50.jpg)
How to prevent a prescribing Cascade
Begin new Rx at low doses & individualise the dose.Expect new symptoms (new Rx, dose change)Ask patient about new unusual symptoms (new Rx – dose changed)Keep patients informed about possible ADRs & what to do if ADRs occur.
Before prescribing a second Rx to treat ADRs of the first Rx the benefits of the first Rx must outweigh the risks of additional ADRs from the second Rx.
![Page 51: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/51.jpg)
Summary
• Changes in physiology of the elderly dictate responses to drug therapy.• P/K changes affect SDCs.• P/D changes affect response.• ADRs are more common in the elderly.• Better primary care can decrease
ADRs.
![Page 52: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/52.jpg)
Useful guideline
‘S.A.I.L Protocol’
![Page 53: Pitfalls in Pharmacotherapy of Geriatrics DR Ali M. Alyami (M Pharm., PhD)](https://reader035.fdocuments.in/reader035/viewer/2022062315/5697bfa31a28abf838c96728/html5/thumbnails/53.jpg)
Thank you